Complementary Therapies for the Reduction of Side Effects During Chemotherapy for Breast Cancer
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine wether a complementary therapy consisting of a
combined medication of selenium, milk thistle, goldenrod and bromelain and a consultation
concerning nutrition and physical activity can reduce side effects of a chemotherapy in
breast cancer patients.
Phase:
Phase 4
Details
Lead Sponsor:
Heidelberg University
Collaborators:
Cefak KG, Kempten H. W. & J. Hector-Stiftung, Weinheim Hector-Stiftung Schwabe-Wenex International Ltd Ursapharm, Saarbrücken